BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35124696)

  • 1. SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.
    Lin L; Shi K; Zhou S; Cai MC; Zhang C; Sun Y; Zang J; Cheng L; Ye K; Ma P; Shen P; Zhang M; Cheng Y; Qi C; Li Y; Yin X; Zheng Y; Tan L; Zhuang G; Zang R
    Oncogene; 2022 Mar; 41(12):1767-1779. PubMed ID: 35124696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.
    Chaves-Moreira D; Mitchell MA; Arruza C; Rawat P; Sidoli S; Nameki R; Reddy J; Corona RI; Afeyan LK; Klein IA; Ma S; Winterhoff B; Konecny GE; Garcia BA; Brady DC; Lawrenson K; Morin PJ; Drapkin R
    Sci Signal; 2022 Apr; 15(728):eabm2496. PubMed ID: 35380877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors.
    Shi K; Yin X; Cai MC; Yan Y; Jia C; Ma P; Zhang S; Zhang Z; Gu Z; Zhang M; Di W; Zhuang G
    Elife; 2019 May; 8():. PubMed ID: 31050342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying SOX17 as a Sensitive and Specific Marker for Ovarian and Endometrial Carcinomas.
    Shaker N; Chen W; Sinclair W; Parwani AV; Li Z
    Mod Pathol; 2023 Jan; 36(1):100038. PubMed ID: 36788073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
    de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
    Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 7. SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas.
    Zhang X; Yao J; Niu N; Li X; Liu Y; Huo L; Euscher ED; Wang H; Bell D; Sood AK; Wang G; Lawson BC; Ramalingam P; Malpica A; Sahin AA; Ding Q; Liu J
    Mod Pathol; 2023 Feb; 36(2):100001. PubMed ID: 36853778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton.
    Hardy LR; Pergande MR; Esparza K; Heath KN; Önyüksel H; Cologna SM; Burdette JE
    Oncogene; 2019 Aug; 38(32):6003-6016. PubMed ID: 31296958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PAX8 expression promotes the proliferation of stomach Cancer cells.
    Bie LY; Li N; Deng WY; Lu XY; Guo P; Luo SX
    BMC Mol Cell Biol; 2019 Dec; 20(1):61. PubMed ID: 31881968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX8 and MECOM are interaction partners driving ovarian cancer.
    Bleu M; Mermet-Meillon F; Apfel V; Barys L; Holzer L; Bachmann Salvy M; Lopes R; Amorim Monteiro Barbosa I; Delmas C; Hinniger A; Chau S; Kaufmann M; Haenni S; Berneiser K; Wahle M; Moravec I; Vissières A; Poetsch T; Ahrné E; Carte N; Voshol J; Bechter E; Hamon J; Meyerhofer M; Erdmann D; Fischer M; Stachyra T; Freuler F; Gutmann S; Fernández C; Schmelzle T; Naumann U; Roma G; Lawrenson K; Nieto-Oberhuber C; Cobos-Correa A; Ferretti S; Schübeler D; Galli GG
    Nat Commun; 2021 Apr; 12(1):2442. PubMed ID: 33903593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube.
    Dinh HQ; Lin X; Abbasi F; Nameki R; Haro M; Olingy CE; Chang H; Hernandez L; Gayther SA; Wright KN; Aspuria PJ; Karlan BY; Corona RI; Li A; Rimel BJ; Siedhoff MT; Medeiros F; Lawrenson K
    Cell Rep; 2021 Apr; 35(2):108978. PubMed ID: 33852846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-derived mesenchymal stem cells induced PAX8 promotes ovarian cancer cell growth by stabilizing TAZ protein.
    Chu Y; Zhu C; Wang Q; Liu M; Wan W; Zhou J; Han R; Yang J; Luo W; Liu C; Zhou H; Li M; Yu F; Ye Y
    J Cell Mol Med; 2021 May; 25(9):4434-4443. PubMed ID: 33830648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rewiring of master transcription factor cistromes during high-grade serous ovarian cancer development.
    Nameki RA; Chang H; Yu P; Abbasi F; Lin X; Reddy J; Haro M; Fonseca MA; Freedman ML; Drapkin R; Corona RI; Lawrenson K
    bioRxiv; 2023 Apr; ():. PubMed ID: 37090516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.
    Cheung HW; Cowley GS; Weir BA; Boehm JS; Rusin S; Scott JA; East A; Ali LD; Lizotte PH; Wong TC; Jiang G; Hsiao J; Mermel CH; Getz G; Barretina J; Gopal S; Tamayo P; Gould J; Tsherniak A; Stransky N; Luo B; Ren Y; Drapkin R; Bhatia SN; Mesirov JP; Garraway LA; Meyerson M; Lander ES; Root DE; Hahn WC
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12372-7. PubMed ID: 21746896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox17 promotes cell cycle progression and inhibits TGF-beta/Smad3 signaling to initiate progenitor cell behavior in the respiratory epithelium.
    Lange AW; Keiser AR; Wells JM; Zorn AM; Whitsett JA
    PLoS One; 2009 May; 4(5):e5711. PubMed ID: 19479035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.
    Corona RI; Seo JH; Lin X; Hazelett DJ; Reddy J; Fonseca MAS; Abassi F; Lin YG; Mhawech-Fauceglia PY; Shah SP; Huntsman DG; Gusev A; Karlan BY; Berman BP; Freedman ML; Gayther SA; Lawrenson K
    Nat Commun; 2020 Apr; 11(1):2020. PubMed ID: 32332753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells.
    Di Palma T; Lucci V; de Cristofaro T; Filippone MG; Zannini M
    BMC Cancer; 2014 Apr; 14():292. PubMed ID: 24766781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.
    Liu X; Luo M; Xie W; Wells JM; Goodheart MJ; Engelhardt JF
    Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L694-710. PubMed ID: 20802155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX8, an Emerging Player in Ovarian Cancer.
    Gokulnath P; Soriano AA; de Cristofaro T; Di Palma T; Zannini M
    Adv Exp Med Biol; 2021; 1330():95-112. PubMed ID: 34339032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.